Shareholders Equity (Quarterly)

Shareholders Equity: The sum of preferred and common equity items.

bioAffinity Technologies, Inc. (BIAF) had Shareholders Equity of $8.90M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$1.45M
Net Income	$-5.05M
Cost of Goods Sold	$0.94M
Gross Profit	$0.50M
Operating Expenses	$3.74M
Operating Income	$-2.29M
Non-Operating Income/Expense	$-2.76M
Pre-Tax Income	$-5.05M
Normalized Pre-Tax Income	$-5.05M
Income after Taxes	$-5.05M
Income from Continuous Operations	$-5.05M
Consolidated Net Income/Loss	$-5.05M
Normalized Income after Taxes	$-5.05M
EBIT	$-2.29M
EBITDA	$-2.18M
Weighted-Average Shares Outstanding (Basic)	1.07M
Weighted-Average Shares Outstanding (Diluted)	1.07M
Earnings per Share (EPS) (Basic)	$-4.74
Earnings per Share (EPS) (Diluted)	$-4.74
Balance Sheet Financials
Current Assets	$8.61M
Property, Plant, and Equipment	$0.30M
Long-Term Assets	$2.93M
Total Assets	$11.55M
Current Liabilities	$2.36M
Long-Term Debt	$0.05M
Long-Term Liabilities	$0.28M
Total Liabilities	$2.64M
Common Equity	$8.90M
Tangible Shareholders Equity	$6.77M
Shareholders Equity	$8.90M
Common Shares Outstanding	3.47M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-6.77M
Cash Flow from Investing Activities	$-0.06M
Cash Flow from Financial Activities	$13.39M
Beginning Cash	$1.11M
End Cash	$7.67M
Increase/Decrease in Cash	$6.56M
Stock-Based Compensation	$0.61M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.65
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.01
Debt to Equity Ratio	0.03
Gross Margin	34.84%
Operating Margin	-158.56%
EBIT Margin	-158.56%
EBITDA Margin	--
Pre-Tax Profit Margin	-349.08%
Profit Margin	-349.30%
Free Cash Flow	$-6.83M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.13
Inventory Turnover	26.74
Receiveable Turnover	3.22
Days Sales in Receivables	27.94
Return on Equity	-56.74%
Return on Tangible Equity	-74.65%
Return on Assets	-43.75%
Return on Investments	-56.45%
Book Value Per Share	$2.57
Free Cash Flow per Share	$-6.40
Operating Cash Flow per Share	$-6.35

Data from Zacks Investment Research, Inc.